Home » Newsletters » BioWorld Science

BioWorld Science

March 8, 2012

View Archived Issues

Novel kinase inhibitors patented

Fatty acid blocks HIV-1 infection in ex vivo cervical tissue model

HCV NS3 resistance variants detected after 7-day MK-5172 course

Strategic alliance aims to develop and commercialize new vaccines

Telormedix receives funding to develop Toll-like receptor 7 modulators

Abbott reports novel inhibitors of GlyT1

New sodium/glucose cotransporter 2 inhibitors developed in China

Roche discovers new HSL inhibitors

Scientists in Brazil identify new phosphodiesterase 5 inhibitors

Novel tablet for type 2 diabetes available in U.S. pharmacies

Horizon Pharma and Mundipharma amend commercialization agreement

Plant-derived lactic acid bacteria may help combat obesity

New anti-infectives designed at Merck & Co.

French company presents novel inhibitors of TNF-alpha

Antigen-specific MS therapy in phase I development

Mersana partners to develop novel antibody-drug conjugates

Courtagen and Avaxia join forces to create new assay

Sosei commences Japanese phase I study of antifungal

Exonhit receives E.U. grant for consortium work on predictive biomarkers

NME improves cognition in schizophrenia model

Alexza and Ferrer amend commercial partnership for Adasuve

ReGenx and Asklepios establish agreement for hemophilia A

Feraheme shows noninferiority to intravenous iron sucrose in iron deficiency anemia

KBP BioSciences reports new mineralocorticoid receptor antagonists

New diacylglycerol O-acyltransferase 1 inhibitors reported by Merck & Co.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...